+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Asthma Therapeutics Market Research Report by Drug Class (Anti-inflammatory, Bronchodilators, and Combination Therapy), Product, Route of administration, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2027 - Cumulative Impact of COVID-19

  • PDF Icon

    Report

  • 229 Pages
  • July 2022
  • Region: Global
  • 360iResearch™
  • ID: 5313729
UP TO OFF until Dec 31st 2022
The Global Asthma Therapeutics Market size was estimated at USD 20.31 billion in 2021, USD 22.39 billion in 2022, and is projected to grow at a CAGR 10.44% to reach USD 36.87 billion by 2027.

Market Statistics:


The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Asthma Therapeutics to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Drug Class, the market was studied across Anti-inflammatory, Bronchodilators, and Combination Therapy.
  • Based on Product, the market was studied across Inhalers and Nebulizers. The Inhalers is further studied across Dry Powder Inhalers, Metered-dose Inhalers, and Soft Mist Inhalers.
  • Based on Route of administration, the market was studied across Inhaled and Oral.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:


We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Asthma Therapeutics market considering the current update on the conflict and its global response.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Asthma Therapeutics Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Asthma Therapeutics Market, including Abbott Laboratories, Amgen Inc., AstraZeneca PLC, Becton, Dickinson and Company, Biogen Inc., Boehringer Ingelheim GmbH, Chiesi Farmaceutici S.p.A., F. Hoffmann-La Roche AG, GlaxoSmithKline PLC, Kare Medical and Analytical Devices Ltd. Co., Koninklijke Philips N.V., Merck & Co. Inc., Merxin Ltd., Novartis AG, Parekhplast India Limited, Regeneron Pharmaceuticals, Inc., Sanofi S.A., Shenzhen Aeon Technology Co., Ltd., Softhale NV, Sunovion Pharmaceuticals, Inc., Teva Pharmaceutical Industries Ltd., Trudell Medical Limited, Viatris Inc., and Wellinks, Inc..

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global Asthma Therapeutics Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Asthma Therapeutics Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Asthma Therapeutics Market?
4. What is the competitive strategic window for opportunities in the Global Asthma Therapeutics Market?
5. What are the technology trends and regulatory frameworks in the Global Asthma Therapeutics Market?
6. What is the market share of the leading vendors in the Global Asthma Therapeutics Market?
7. What modes and strategic moves are considered suitable for entering the Global Asthma Therapeutics Market?
Frequently Asked Questions about the Global Asthma Therapeutics Market

What is the estimated value of the Global Asthma Therapeutics Market?

The Global Asthma Therapeutics Market was estimated to be valued at $20.31 Billion in 2021.

What is the growth rate of the Global Asthma Therapeutics Market?

The growth rate of the Global Asthma Therapeutics Market is 10.4%, with an estimated value of $36.87 Billion by 2027.

What is the forecasted size of the Global Asthma Therapeutics Market?

The Global Asthma Therapeutics Market is estimated to be worth $36.87 Billion by 2027.

Who are the key companies in the Global Asthma Therapeutics Market?

Key companies in the Global Asthma Therapeutics Market include Abbott Laboratories, Amgen Inc., AstraZeneca PLC, Becton, Dickinson and Company, Biogen Inc., Boehringer Ingelheim GmbH, Chiesi Farmaceutici S.p.A., F. Hoffmann and GlaxoSmithKline PLC.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing Incidences of Asthma and Other Respiratory Diseases
5.1.1.2. Recent Improvements in Allergy Detection and Diagnostic Technologies
5.1.1.3. Extensive Demand for Monoclonal Antibodies
5.1.2. Restraints
5.1.2.1. Limitation and Side Effects of Asthma Therapeutic Devices
5.1.3. Opportunities
5.1.3.1. Development of Combination Therapeutics for the Treatment
5.1.3.2. Extensive Research and Development (R&D) Efforts for Asthma Treatment
5.1.4. Challenges
5.1.4.1. Limited Therapeutics Reach in Remote & Rural Areas
5.2. Cumulative Impact of COVID-19
6. Asthma Therapeutics Market, by Drug Class
6.1. Introduction
6.2. Anti-Inflammatory
6.3. Bronchodilators
6.4. Combination Therapy
7. Asthma Therapeutics Market, by Product
7.1. Introduction
7.2. Inhalers
7.2.1. Dry Powder Inhalers
7.2.2. Metered-Dose Inhalers
7.2.3. Soft Mist Inhalers
7.3. Nebulizers
8. Asthma Therapeutics Market, by Route of Administration
8.1. Introduction
8.2. Inhaled
8.3. Oral
9. Americas Asthma Therapeutics Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Asthma Therapeutics Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
11. Europe, Middle East & Africa Asthma Therapeutics Market
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom
12. Competitive Landscape
12.1. Fpnv Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis, by Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion
13. Company Usability Profiles
13.1. Abbott Laboratories
13.2. Amgen Inc.
13.3. Astrazeneca plc
13.4. Becton, Dickinson and Company
13.5. Biogen Inc.
13.6. Boehringer Ingelheim GmbH
13.7. Chiesi Farmaceutici S.P.A.
13.8. F. Hoffmann-La Roche Ag
13.9. GlaxoSmithKline plc
13.10. Kare Medical and Analytical Devices Ltd. Co.
13.11. Koninklijke Philips N.V.
13.12. Merck & Co. Inc.
13.13. Merxin Ltd.
13.14. Novartis Ag
13.15. Parekhplast India Limited
13.16. Regeneron Pharmaceuticals, Inc.
13.17. Sanofi S.A.
13.18. Shenzhen Aeon Technology Co., Ltd.
13.19. Softhale Nv
13.20. Sunovion Pharmaceuticals, Inc.
13.21. Teva Pharmaceutical Industries Ltd.
13.22. Trudell Medical Limited
13.23. Viatris Inc.
13.24. Wellinks, Inc.
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
List of Figures
FIGURE 1. GLOBAL ASTHMA THERAPEUTICS MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL ASTHMA THERAPEUTICS MARKET SIZE, 2021 VS 2027 (USD MILLION)
FIGURE 3. GLOBAL ASTHMA THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 4. GLOBAL ASTHMA THERAPEUTICS MARKET SIZE, BY REGION, 2021 VS 2027 (%)
FIGURE 5. GLOBAL ASTHMA THERAPEUTICS MARKET SIZE, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 6. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ASTHMA THERAPEUTICS MARKET SIZE, BY REGION, 2027
FIGURE 7. GLOBAL ASTHMA THERAPEUTICS MARKET DYNAMICS
FIGURE 8. GLOBAL ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2021 VS 2027 (%)
FIGURE 9. GLOBAL ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2021 VS 2027 (USD MILLION)
FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2027
FIGURE 11. GLOBAL ASTHMA THERAPEUTICS MARKET SIZE, BY ANTI-INFLAMMATORY, 2019-2027 (USD MILLION)
FIGURE 12. GLOBAL ASTHMA THERAPEUTICS MARKET SIZE, BY ANTI-INFLAMMATORY, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 13. GLOBAL ASTHMA THERAPEUTICS MARKET SIZE, BY BRONCHODILATORS, 2019-2027 (USD MILLION)
FIGURE 14. GLOBAL ASTHMA THERAPEUTICS MARKET SIZE, BY BRONCHODILATORS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 15. GLOBAL ASTHMA THERAPEUTICS MARKET SIZE, BY COMBINATION THERAPY, 2019-2027 (USD MILLION)
FIGURE 16. GLOBAL ASTHMA THERAPEUTICS MARKET SIZE, BY COMBINATION THERAPY, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 17. GLOBAL ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2021 VS 2027 (%)
FIGURE 18. GLOBAL ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2021 VS 2027 (USD MILLION)
FIGURE 19. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2027
FIGURE 20. GLOBAL ASTHMA THERAPEUTICS MARKET SIZE, BY INHALERS, 2019-2027 (USD MILLION)
FIGURE 21. GLOBAL ASTHMA THERAPEUTICS MARKET SIZE, BY INHALERS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 22. GLOBAL ASTHMA THERAPEUTICS MARKET SIZE, BY DRY POWDER INHALERS, 2019-2027 (USD MILLION)
FIGURE 23. GLOBAL ASTHMA THERAPEUTICS MARKET SIZE, BY DRY POWDER INHALERS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 24. GLOBAL ASTHMA THERAPEUTICS MARKET SIZE, BY METERED-DOSE INHALERS, 2019-2027 (USD MILLION)
FIGURE 25. GLOBAL ASTHMA THERAPEUTICS MARKET SIZE, BY METERED-DOSE INHALERS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 26. GLOBAL ASTHMA THERAPEUTICS MARKET SIZE, BY SOFT MIST INHALERS, 2019-2027 (USD MILLION)
FIGURE 27. GLOBAL ASTHMA THERAPEUTICS MARKET SIZE, BY SOFT MIST INHALERS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 28. GLOBAL ASTHMA THERAPEUTICS MARKET SIZE, BY NEBULIZERS, 2019-2027 (USD MILLION)
FIGURE 29. GLOBAL ASTHMA THERAPEUTICS MARKET SIZE, BY NEBULIZERS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 30. GLOBAL ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2021 VS 2027 (%)
FIGURE 31. GLOBAL ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2021 VS 2027 (USD MILLION)
FIGURE 32. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2027
FIGURE 33. GLOBAL ASTHMA THERAPEUTICS MARKET SIZE, BY INHALED, 2019-2027 (USD MILLION)
FIGURE 34. GLOBAL ASTHMA THERAPEUTICS MARKET SIZE, BY INHALED, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 35. GLOBAL ASTHMA THERAPEUTICS MARKET SIZE, BY ORAL, 2019-2027 (USD MILLION)
FIGURE 36. GLOBAL ASTHMA THERAPEUTICS MARKET SIZE, BY ORAL, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 37. AMERICAS ASTHMA THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 38. AMERICAS ASTHMA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 39. AMERICAS ASTHMA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 40. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS ASTHMA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2027
FIGURE 41. ARGENTINA ASTHMA THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 42. BRAZIL ASTHMA THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 43. CANADA ASTHMA THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 44. MEXICO ASTHMA THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 45. UNITED STATES ASTHMA THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 46. UNITED STATES ASTHMA THERAPEUTICS MARKET SIZE, BY STATE, 2021 VS 2027 (%)
FIGURE 47. UNITED STATES ASTHMA THERAPEUTICS MARKET SIZE, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 48. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES ASTHMA THERAPEUTICS MARKET SIZE, BY STATE, 2027
FIGURE 49. ASIA-PACIFIC ASTHMA THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 50. ASIA-PACIFIC ASTHMA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 51. ASIA-PACIFIC ASTHMA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 52. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC ASTHMA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2027
FIGURE 53. AUSTRALIA ASTHMA THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 54. CHINA ASTHMA THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 55. INDIA ASTHMA THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 56. INDONESIA ASTHMA THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 57. JAPAN ASTHMA THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 58. MALAYSIA ASTHMA THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 59. PHILIPPINES ASTHMA THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 60. SINGAPORE ASTHMA THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 61. SOUTH KOREA ASTHMA THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 62. TAIWAN ASTHMA THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 63. THAILAND ASTHMA THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 64. EUROPE, MIDDLE EAST & AFRICA ASTHMA THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 65. EUROPE, MIDDLE EAST & AFRICA ASTHMA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 66. EUROPE, MIDDLE EAST & AFRICA ASTHMA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 67. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA ASTHMA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2027
FIGURE 68. FRANCE ASTHMA THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 69. GERMANY ASTHMA THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 70. ITALY ASTHMA THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 71. NETHERLANDS ASTHMA THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 72. QATAR ASTHMA THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 73. RUSSIA ASTHMA THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 74. SAUDI ARABIA ASTHMA THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 75. SOUTH AFRICA ASTHMA THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 76. SPAIN ASTHMA THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 77. UNITED ARAB EMIRATES ASTHMA THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 78. UNITED KINGDOM ASTHMA THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 79. GLOBAL ASTHMA THERAPEUTICS MARKET: FPNV POSITIONING MATRIX, 2021
FIGURE 80. GLOBAL ASTHMA THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2021
FIGURE 81. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL ASTHMA THERAPEUTICS MARKET, BY TYPE
List of Tables
TABLE 1. GLOBAL ASTHMA THERAPEUTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. GLOBAL ASTHMA THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 4. GLOBAL ASTHMA THERAPEUTICS MARKET SIZE, BY REGION, 2019-2027 (USD MILLION)
TABLE 5. GLOBAL ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2019-2027 (USD MILLION)
TABLE 6. GLOBAL ASTHMA THERAPEUTICS MARKET SIZE, BY ANTI-INFLAMMATORY, BY REGION, 2019-2027 (USD MILLION)
TABLE 7. AMERICAS ASTHMA THERAPEUTICS MARKET SIZE, BY ANTI-INFLAMMATORY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 8. UNITED STATES ASTHMA THERAPEUTICS MARKET SIZE, BY ANTI-INFLAMMATORY, BY STATE, 2019-2027 (USD MILLION)
TABLE 9. ASIA-PACIFIC ASTHMA THERAPEUTICS MARKET SIZE, BY ANTI-INFLAMMATORY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 10. EUROPE, MIDDLE EAST & AFRICA ASTHMA THERAPEUTICS MARKET SIZE, BY ANTI-INFLAMMATORY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 11. GLOBAL ASTHMA THERAPEUTICS MARKET SIZE, BY BRONCHODILATORS, BY REGION, 2019-2027 (USD MILLION)
TABLE 12. AMERICAS ASTHMA THERAPEUTICS MARKET SIZE, BY BRONCHODILATORS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 13. UNITED STATES ASTHMA THERAPEUTICS MARKET SIZE, BY BRONCHODILATORS, BY STATE, 2019-2027 (USD MILLION)
TABLE 14. ASIA-PACIFIC ASTHMA THERAPEUTICS MARKET SIZE, BY BRONCHODILATORS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 15. EUROPE, MIDDLE EAST & AFRICA ASTHMA THERAPEUTICS MARKET SIZE, BY BRONCHODILATORS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 16. GLOBAL ASTHMA THERAPEUTICS MARKET SIZE, BY COMBINATION THERAPY, BY REGION, 2019-2027 (USD MILLION)
TABLE 17. AMERICAS ASTHMA THERAPEUTICS MARKET SIZE, BY COMBINATION THERAPY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 18. UNITED STATES ASTHMA THERAPEUTICS MARKET SIZE, BY COMBINATION THERAPY, BY STATE, 2019-2027 (USD MILLION)
TABLE 19. ASIA-PACIFIC ASTHMA THERAPEUTICS MARKET SIZE, BY COMBINATION THERAPY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 20. EUROPE, MIDDLE EAST & AFRICA ASTHMA THERAPEUTICS MARKET SIZE, BY COMBINATION THERAPY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 21. GLOBAL ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 22. GLOBAL ASTHMA THERAPEUTICS MARKET SIZE, BY INHALERS, BY REGION, 2019-2027 (USD MILLION)
TABLE 23. AMERICAS ASTHMA THERAPEUTICS MARKET SIZE, BY INHALERS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 24. UNITED STATES ASTHMA THERAPEUTICS MARKET SIZE, BY INHALERS, BY STATE, 2019-2027 (USD MILLION)
TABLE 25. ASIA-PACIFIC ASTHMA THERAPEUTICS MARKET SIZE, BY INHALERS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 26. EUROPE, MIDDLE EAST & AFRICA ASTHMA THERAPEUTICS MARKET SIZE, BY INHALERS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 27. GLOBAL ASTHMA THERAPEUTICS MARKET SIZE, BY DRY POWDER INHALERS, BY REGION, 2019-2027 (USD MILLION)
TABLE 28. AMERICAS ASTHMA THERAPEUTICS MARKET SIZE, BY DRY POWDER INHALERS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 29. UNITED STATES ASTHMA THERAPEUTICS MARKET SIZE, BY DRY POWDER INHALERS, BY STATE, 2019-2027 (USD MILLION)
TABLE 30. ASIA-PACIFIC ASTHMA THERAPEUTICS MARKET SIZE, BY DRY POWDER INHALERS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 31. EUROPE, MIDDLE EAST & AFRICA ASTHMA THERAPEUTICS MARKET SIZE, BY DRY POWDER INHALERS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 32. GLOBAL ASTHMA THERAPEUTICS MARKET SIZE, BY METERED-DOSE INHALERS, BY REGION, 2019-2027 (USD MILLION)
TABLE 33. AMERICAS ASTHMA THERAPEUTICS MARKET SIZE, BY METERED-DOSE INHALERS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 34. UNITED STATES ASTHMA THERAPEUTICS MARKET SIZE, BY METERED-DOSE INHALERS, BY STATE, 2019-2027 (USD MILLION)
TABLE 35. ASIA-PACIFIC ASTHMA THERAPEUTICS MARKET SIZE, BY METERED-DOSE INHALERS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 36. EUROPE, MIDDLE EAST & AFRICA ASTHMA THERAPEUTICS MARKET SIZE, BY METERED-DOSE INHALERS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 37. GLOBAL ASTHMA THERAPEUTICS MARKET SIZE, BY SOFT MIST INHALERS, BY REGION, 2019-2027 (USD MILLION)
TABLE 38. AMERICAS ASTHMA THERAPEUTICS MARKET SIZE, BY SOFT MIST INHALERS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 39. UNITED STATES ASTHMA THERAPEUTICS MARKET SIZE, BY SOFT MIST INHALERS, BY STATE, 2019-2027 (USD MILLION)
TABLE 40. ASIA-PACIFIC ASTHMA THERAPEUTICS MARKET SIZE, BY SOFT MIST INHALERS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 41. EUROPE, MIDDLE EAST & AFRICA ASTHMA THERAPEUTICS MARKET SIZE, BY SOFT MIST INHALERS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 42. GLOBAL ASTHMA THERAPEUTICS MARKET SIZE, BY NEBULIZERS, BY REGION, 2019-2027 (USD MILLION)
TABLE 43. AMERICAS ASTHMA THERAPEUTICS MARKET SIZE, BY NEBULIZERS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 44. UNITED STATES ASTHMA THERAPEUTICS MARKET SIZE, BY NEBULIZERS, BY STATE, 2019-2027 (USD MILLION)
TABLE 45. ASIA-PACIFIC ASTHMA THERAPEUTICS MARKET SIZE, BY NEBULIZERS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 46. EUROPE, MIDDLE EAST & AFRICA ASTHMA THERAPEUTICS MARKET SIZE, BY NEBULIZERS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 47. GLOBAL ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 48. GLOBAL ASTHMA THERAPEUTICS MARKET SIZE, BY INHALED, BY REGION, 2019-2027 (USD MILLION)
TABLE 49. AMERICAS ASTHMA THERAPEUTICS MARKET SIZE, BY INHALED, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 50. UNITED STATES ASTHMA THERAPEUTICS MARKET SIZE, BY INHALED, BY STATE, 2019-2027 (USD MILLION)
TABLE 51. ASIA-PACIFIC ASTHMA THERAPEUTICS MARKET SIZE, BY INHALED, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 52. EUROPE, MIDDLE EAST & AFRICA ASTHMA THERAPEUTICS MARKET SIZE, BY INHALED, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 53. GLOBAL ASTHMA THERAPEUTICS MARKET SIZE, BY ORAL, BY REGION, 2019-2027 (USD MILLION)
TABLE 54. AMERICAS ASTHMA THERAPEUTICS MARKET SIZE, BY ORAL, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 55. UNITED STATES ASTHMA THERAPEUTICS MARKET SIZE, BY ORAL, BY STATE, 2019-2027 (USD MILLION)
TABLE 56. ASIA-PACIFIC ASTHMA THERAPEUTICS MARKET SIZE, BY ORAL, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 57. EUROPE, MIDDLE EAST & AFRICA ASTHMA THERAPEUTICS MARKET SIZE, BY ORAL, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 58. AMERICAS ASTHMA THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 59. AMERICAS ASTHMA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 60. AMERICAS ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2019-2027 (USD MILLION)
TABLE 61. AMERICAS ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 62. AMERICAS ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 63. ARGENTINA ASTHMA THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 64. ARGENTINA ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2019-2027 (USD MILLION)
TABLE 65. ARGENTINA ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 66. ARGENTINA ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 67. BRAZIL ASTHMA THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 68. BRAZIL ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2019-2027 (USD MILLION)
TABLE 69. BRAZIL ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 70. BRAZIL ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 71. CANADA ASTHMA THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 72. CANADA ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2019-2027 (USD MILLION)
TABLE 73. CANADA ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 74. CANADA ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 75. MEXICO ASTHMA THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 76. MEXICO ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2019-2027 (USD MILLION)
TABLE 77. MEXICO ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 78. MEXICO ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 79. UNITED STATES ASTHMA THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 80. UNITED STATES ASTHMA THERAPEUTICS MARKET SIZE, BY STATE, 2019-2027 (USD MILLION)
TABLE 81. UNITED STATES ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2019-2027 (USD MILLION)
TABLE 82. UNITED STATES ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 83. UNITED STATES ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 84. ASIA-PACIFIC ASTHMA THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 85. ASIA-PACIFIC ASTHMA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 86. ASIA-PACIFIC ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2019-2027 (USD MILLION)
TABLE 87. ASIA-PACIFIC ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 88. ASIA-PACIFIC ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 89. AUSTRALIA ASTHMA THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 90. AUSTRALIA ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2019-2027 (USD MILLION)
TABLE 91. AUSTRALIA ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 92. AUSTRALIA ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 93. CHINA ASTHMA THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 94. CHINA ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2019-2027 (USD MILLION)
TABLE 95. CHINA ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 96. CHINA ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 97. INDIA ASTHMA THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 98. INDIA ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2019-2027 (USD MILLION)
TABLE 99. INDIA ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 100. INDIA ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 101. INDONESIA ASTHMA THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 102. INDONESIA ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2019-2027 (USD MILLION)
TABLE 103. INDONESIA ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 104. INDONESIA ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 105. JAPAN ASTHMA THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 106. JAPAN ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2019-2027 (USD MILLION)
TABLE 107. JAPAN ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 108. JAPAN ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 109. MALAYSIA ASTHMA THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 110. MALAYSIA ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2019-2027 (USD MILLION)
TABLE 111. MALAYSIA ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 112. MALAYSIA ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 113. PHILIPPINES ASTHMA THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 114. PHILIPPINES ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2019-2027 (USD MILLION)
TABLE 115. PHILIPPINES ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 116. PHILIPPINES ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 117. SINGAPORE ASTHMA THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 118. SINGAPORE ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2019-2027 (USD MILLION)
TABLE 119. SINGAPORE ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 120. SINGAPORE ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 121. SOUTH KOREA ASTHMA THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 122. SOUTH KOREA ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2019-2027 (USD MILLION)
TABLE 123. SOUTH KOREA ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 124. SOUTH KOREA ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 125. TAIWAN ASTHMA THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 126. TAIWAN ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2019-2027 (USD MILLION)
TABLE 127. TAIWAN ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 128. TAIWAN ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 129. THAILAND ASTHMA THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 130. THAILAND ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2019-2027 (USD MILLION)
TABLE 131. THAILAND ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 132. THAILAND ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 133. EUROPE, MIDDLE EAST & AFRICA ASTHMA THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 134. EUROPE, MIDDLE EAST & AFRICA ASTHMA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 135. EUROPE, MIDDLE EAST & AFRICA ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2019-2027 (USD MILLION)
TABLE 136. EUROPE, MIDDLE EAST & AFRICA ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 137. EUROPE, MIDDLE EAST & AFRICA ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 138. FRANCE ASTHMA THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 139. FRANCE ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2019-2027 (USD MILLION)
TABLE 140. FRANCE ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 141. FRANCE ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 142. GERMANY ASTHMA THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 143. GERMANY ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2019-2027 (USD MILLION)
TABLE 144. GERMANY ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 145. GERMANY ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 146. ITALY ASTHMA THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 147. ITALY ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2019-2027 (USD MILLION)
TABLE 148. ITALY ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 149. ITALY ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 150. NETHERLANDS ASTHMA THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 151. NETHERLANDS ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2019-2027 (USD MILLION)
TABLE 152. NETHERLANDS ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 153. NETHERLANDS ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 154. QATAR ASTHMA THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 155. QATAR ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2019-2027 (USD MILLION)
TABLE 156. QATAR ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 157. QATAR ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 158. RUSSIA ASTHMA THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 159. RUSSIA ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2019-2027 (USD MILLION)
TABLE 160. RUSSIA ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 161. RUSSIA ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 162. SAUDI ARABIA ASTHMA THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 163. SAUDI ARABIA ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2019-2027 (USD MILLION)
TABLE 164. SAUDI ARABIA ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 165. SAUDI ARABIA ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 166. SOUTH AFRICA ASTHMA THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 167. SOUTH AFRICA ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2019-2027 (USD MILLION)
TABLE 168. SOUTH AFRICA ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 169. SOUTH AFRICA ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 170. SPAIN ASTHMA THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 171. SPAIN ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2019-2027 (USD MILLION)
TABLE 172. SPAIN ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 173. SPAIN ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 174. UNITED ARAB EMIRATES ASTHMA THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 175. UNITED ARAB EMIRATES ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2019-2027 (USD MILLION)
TABLE 176. UNITED ARAB EMIRATES ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 177. UNITED ARAB EMIRATES ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 178. UNITED KINGDOM ASTHMA THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 179. UNITED KINGDOM ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2019-2027 (USD MILLION)
TABLE 180. UNITED KINGDOM ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 181. UNITED KINGDOM ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 182. GLOBAL ASTHMA THERAPEUTICS MARKET: FPNV POSITIONING MATRIX - SCORES, 2021
TABLE 183. GLOBAL ASTHMA THERAPEUTICS MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2021
TABLE 184. GLOBAL ASTHMA THERAPEUTICS MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2021
TABLE 185. GLOBAL ASTHMA THERAPEUTICS MARKET RANKING
TABLE 186. GLOBAL ASTHMA THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2021
TABLE 187. GLOBAL ASTHMA THERAPEUTICS MARKET MERGER & ACQUISITION
TABLE 188. GLOBAL ASTHMA THERAPEUTICS MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 189. GLOBAL ASTHMA THERAPEUTICS MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 190. GLOBAL ASTHMA THERAPEUTICS MARKET INVESTMENT & FUNDING
TABLE 191. GLOBAL ASTHMA THERAPEUTICS MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 192. GLOBAL ASTHMA THERAPEUTICS MARKET: LICENSE & PRICING

Companies Mentioned

  • Abbott Laboratories
  • Amgen Inc.
  • AstraZeneca PLC
  • Becton, Dickinson and Company
  • Biogen Inc.
  • Boehringer Ingelheim GmbH
  • Chiesi Farmaceutici S.p.A.
  • F. Hoffmann-La Roche AG
  • GlaxoSmithKline PLC
  • Kare Medical and Analytical Devices Ltd. Co.
  • Koninklijke Philips N.V.
  • Merck & Co. Inc.
  • Merxin Ltd.
  • Novartis AG
  • Parekhplast India Limited
  • Regeneron Pharmaceuticals, Inc.
  • Sanofi S.A.
  • Shenzhen Aeon Technology Co., Ltd.
  • Softhale NV
  • Sunovion Pharmaceuticals, Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Trudell Medical Limited
  • Viatris Inc.
  • Wellinks, Inc.

Methodology

Loading
LOADING...